-
DAMGO: µ-Opioid Receptor Agonist Workflows
2026-08-31
DAMGO links high-affinity µ-opioid receptor activation to receptor-proximal assays, ex vivo physiology, and circuit-level pain phenotypes. Its selective pharmacology helps distinguish analgesic signaling from opioid-induced mechanical hypersensitivity and tolerance in translational workflows.
-
Kanamycin Sulfate: Research Workflows and Selection
2026-08-31
Kanamycin Sulfate is a water-soluble antibiotic for reproducible bacterial selection, resistance profiling, and mechanistic microbiology workflows. This guide connects practical assay design with the toxin-focused Clostridioides difficile research landscape while showing how to prevent antibiotic carryover from confounding infection and microbiome experiments.
-
Lisinopril Dihydrate: An ACE Assay Playbook
2026-08-30
Lisinopril dihydrate is a powerful ACE inhibitor for mechanistic cardiovascular and renal studies. This assay-focused guide explains how to interpret ACE selectivity, manage hydrate-state and solution variables, and design stronger hypertension, heart failure, and nephropathy experiments.
-
Phosphatase Inhibitor Cocktail (2 Tubes, 100X)
2026-08-29
This dual-component Phosphatase Inhibitor Cocktail is used during sample preparation to limit endogenous dephosphorylation and support protein phosphorylation preservation in immunoblotting, immunoprecipitation, kinase activity assays, and mass spectrometry. It is a research reagent only; assay-specific compatibility must be verified, and it should not be used for diagnostic, clinical, or medical applications.
-
AG-126: ERK Assay Design Beyond Pathway Labels
2026-08-28
AG-126 and Tyrphostin AG-126 provide a research tool for interrogating ERK1/2 phosphorylation, inflammatory signaling, and pathway-dependent phenotypes. This article connects its assay value to a neuroligin–striatal circuit study while clearly separating evidence from hypothesis.
-
QRICH1, ER Stress, and HMGB1 in HBV Fibrosis
2026-08-28
A 2025 Immunobiology study identifies QRICH1 as an important endoplasmic reticulum stress effector that amplifies HBV-associated HMGB1 transcription, translocation, and secretion. Its mouse-model and clinical-specimen data connect ER stress, SIRT6-dependent HMGB1 acetylation, and hepatic fibrosis while defining experimental readouts for studying this pathway.
-
Lisinopril Dihydrate: ACE Inhibition Workflows
2026-08-27
Lisinopril dihydrate provides a practical, water-soluble route to controlled ACE inhibition across enzyme, cellular, cardiovascular, and renal studies. This guide connects concentration planning with peptidase counterscreens, disease-model readouts, and troubleshooting strategies that improve interpretability.
-
Tunicamycin: A Practical N-Glycosylation Inhibitor Guide
2026-08-27
Tunicamycin provides a controllable way to connect disrupted protein N-glycosylation with ER stress, macrophage inflammatory signaling, and lymphocyte dysfunction. This guide translates the reference study into practical assay designs, dose-finding workflows, controls, and troubleshooting strategies.
-
p-Cresyl sulfate: Reliable Assay Workflows
2026-08-26
A scenario-based guide to using p-Cresyl sulfate (SKU A8895) in endothelial proliferation, wound-healing, viability, and cardiovascular disease models. It explains matrix effects, solution preparation, endpoint interpretation, and practical sourcing decisions for reproducible uremic toxin research.
-
Droplet Digital CRISPR-Cas13a for m6A Detection
2026-08-26
The reference study introduces a droplet digital CRISPR-Cas13a method for amplification-free detection of N6-methyladenosine (m6A) in RNA. By combining m6A-specific antibody enrichment with compartmentalized Cas13a analysis, the platform reports femtomolar sensitivity and quantitative estimation of methylation-site proportions without relying on PCR or isothermal amplification.
-
Eicosapentaenoic Acid (EPA) in Cell Assays
2026-08-25
A practical, evidence-based guide to using Eicosapentaenoic Acid (EPA) in cell viability, proliferation, cytotoxicity, and endothelial assays. It explains concentration selection, vehicle controls, handling, interpretation, and vendor qualification for SKU B3464.
-
Baicalein: Designing Mechanism-First Assays
2026-08-25
Baicalein is a 12-LOX-focused flavonoid for investigating cancer cell proliferation inhibition, apoptosis, and inflammation. This guide develops a paired assay strategy informed by a recent chemotherapy-neurotoxicity study, while clearly separating established evidence from testable research hypotheses.
-
Annexin V-Cy5 Apoptosis Kit Guide
2026-08-24
The Annexin V-Cy5 Apoptosis Kit supports rapid Annexin V apoptosis detection by labeling exposed phosphatidylserine with Cy5 for fluorescence microscopy or flow cytometry. It is useful as a membrane-level apoptosis assay, but it does not directly measure lysosomal digestion in stressed microglia.
-
ACE Inhibitor Selectivity Across Aminopeptidases
2026-08-24
Tieku and Hooper directly compared metallopeptidase inhibitors against the cell-surface aminopeptidases AP-A, AP-N, and AP-W, revealing substantial differences in inhibitor selectivity. The study shows why ACE inhibitor activity should not be inferred from potency against unrelated zinc aminopeptidases and provides a framework for evaluating off-target effects in peptide-metabolism research.
-
p-Cresyl Sulfate: From Uremia to Biliary Injury
2026-08-23
Explore how p-Cresyl sulfate, or p-tolyl hydrogen sulfate, connects renal retention, endothelial dysfunction, and biliary epithelial injury. This article translates recent mechanistic evidence into practical assay design decisions for integrated uremic toxin research.